Gene expression levels of cytokines in peritoneal washings from patients with gastric cancer

Tumor Biology

Volumn 25, Issue 3, 2004, Pages 117-121

  Ikeguchi, Masahide ^a   Matsumoto, Sachiko ^a   Murakami, Daiki ^a   Kanaji, Shingo ^a   Ohro, Shotaro ^a   Maeta, Yoshihiko ^a   Tatebe, Shigeru ^a   Kondo, Akira ^a   Tsujitani, Shun Ichi ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cytokine; Gastric cancer; Peritoneal seeding; Peritoneal washing; Real time reverse transcription polymerase chain reaction

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM; PERITONEUM METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH CANCER; BIOSYNTHESIS; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM LAVAGE; PERITONEUM TUMOR; STOMACH TUMOR; TUMOR EMBOLISM;

CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-6; NEOPLASM CIRCULATING CELLS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 4644247552     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079143     Document Type: Article

References (25)

1. Iitsuka Y, Shiota S, Matsui T, Murata Y, Kimura A, Koga S: Relationship between the cytologic characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol 1990;34:437-442.
2. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N: Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994;14:2131-2134.
3. Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Müller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C: Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol 1998;16:1861-1868.
4. Majima T, Ichikura T, Seki S, Takayama E, Hiraide H, Mochizuki H: Interleukin-10 and interferon-gamma levels within the peritoneal cavity of patients with gastric cancer. J Surg Oncol 2001;78:124-130.
5. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H, Hamaoka T: Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 1991;146:1077-1082.
6. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, Grage B, Schmahl M, Knabbe C: Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996;148:1679-1688.
7. Marth C, Lang T, Koza A, Mayer I, Daxenbichler G: Transforming growth factor-beta and ovarian carcinoma cells: Regulation of proliferation and surface antigen expression. Cancer Lett 1990;51:221-225.
8. Siapati KE, Barker S, Kinnon C, Michalski A, Anderson R, Brickell P, Thrasher AJ, Hart SL: Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12. Br J Cancer 2003;88:1641-1648.
9. Jackaman C, Bundell CS, Kinnear BF, Smith AM, Filion P, van Hagen D, Robinson BW, Nelson DJ: IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: A novel mechanism for IL-2. J Immunol 2003;171:5051-5063.
10. Tsung K, Dolan JP, Tsung YL, Norton JA: Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 2002;62:5069-5075.
11. Gallo RL, Dorschner RA, Takashima S, Klagsbrun M, Eriksson E, Bernfield M: Endothelial cell surface alkaline phosphatase activity is induced by IL-6 released during wound repair. J Invest Dermatol 1997;109:597-603.
12. Okamoto M, Lee C, Oyasu R: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 1997;57:141-146.
13. Leu CM, Wong FH, Chang C, Huang SF, Hu CP: Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 2003;22:7809-7818.
14. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998;1:10-24.
15. Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Furuya D, Hirata K, Watanabe N: Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem 1998;44:2441-2445.
16. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robinson JG, Metcalf JS, Palesch YY, Zhang Z, Gillanders WE, Cole DJ: Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001;93:162-171.
17. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T: Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001;61:3550-3555.
18. Ikeguchi M, Ohro S, Maeda Y, Fukuda K, Yamaguchi K, Shirai H, Kondo A, Tsujitani S, Kaibara N: Detection of cancer cells in the peripheral blood of gastric cancer patients. Int J Mol Med 2003;11:217-221.
19. O'Hara RJ, Greenman J, Drew PJ, McDonald AW, Duthie GS, Lee PW, Monson JR: Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer. Dis Colon Rectum 1998;41:460-463.
20. Lissoni P, Mandala M, Curigliano G, Ferretti G, Moro C, Ardizzoia A, Malugani F, Tancini G, Tisi E, Arrigoni C, Barni S: Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2. Oncology 2001;60:308-312.
21. Walia B, Wang L, Merlin D, Sitaraman SV: TGF-β down-regulates IL-6 signaling in intestinal epithelial cells: Critical role of SMAD-2. FASEB J 2003;17:2130-2132.
22. Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutho T, Ohkubo H: Cytohistologic assessment of antitumor effects of intra-peritoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992;70:2754-2760.
23. Jeung HC, Rha SY, Jang WI, Noh SH, Chung HC: Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br J Surg 2002;89:460-466.
24. Shimada S, Tanaka E, Marutsuka T, Honmyo U, Tokunaga H, Yagi Y, Aoki N, Ogawa M: Extensive intraperitoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer 2002;5:168-172.
25. Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF: Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: A phase II study. Am J Clin Oncol 2002;25:619-624.